Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Medulloblastoma × etoposide phosphate × Clear all

Phase

Status

Completed 3 Terminated 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 2 Lymphoma, B-Cell 2 Lymphoma 2 Recurrence 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Nervous System Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Medulloblastoma 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Glioma 1 Ganglioneuroblastoma 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Brain Diseases 1

Interventions

Temozolomide 5 Cyclophosphamide 5 Etoposide 4 Radiotherapy 3 lutetium Lu 177 dotatate 2 Vincristine 2 Radiation 2 Cisplatin 2 sodium thiosulfate 1 pegfilgrastim 1 olaparib 1 ibrutinib 1 fludarabine 1 fenofibric acid 1 etoposide phosphate 1 Topotecan 1 Thalidomide 1 Tablets 1 Standard of Care 1 Specimen Handling 1 Platinum 1 ONC206 1 Methotrexate 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Lomustine 1 Irinotecan 1 Hearing 1 Filgrastim 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡